Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain

  1. Rodríguez López, M.
  2. Megías Vericat, J.E.
  3. Albo López, C.
  4. Bonanad, S.
Journal:
BMJ Case Reports

ISSN: 1757-790X

Year of publication: 2020

Volume: 13

Issue: 10

Type: Article

DOI: 10.1136/BCR-2019-234142 GOOGLE SCHOLAR
Data source: Scopus